CORD-19:f1fd5f33dcbe0aae1ce2efb7b7d22eafb4247f02 / 21871-22214 JSONTXT

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T120","span":{"begin":0,"end":343},"obj":"Sentence"}],"text":"The TELICAST study by Johnston and colleagues showed that patients with asthma exacerbations that were given telithromycin, a ketolide, had an increase in symptom-free days and lung function tests conducted in the clinic compared with control subjects given placebo, but did not have an increase in lung function tests conducted at home (57) ."}

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T120","span":{"begin":0,"end":343},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The TELICAST study by Johnston and colleagues showed that patients with asthma exacerbations that were given telithromycin, a ketolide, had an increase in symptom-free days and lung function tests conducted in the clinic compared with control subjects given placebo, but did not have an increase in lung function tests conducted at home (57) ."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T140","span":{"begin":72,"end":78},"obj":"Phenotype"}],"attributes":[{"id":"A140","pred":"hp_id","subj":"T140","obj":"http://purl.obolibrary.org/obo/HP_0002099"}],"text":"The TELICAST study by Johnston and colleagues showed that patients with asthma exacerbations that were given telithromycin, a ketolide, had an increase in symptom-free days and lung function tests conducted in the clinic compared with control subjects given placebo, but did not have an increase in lung function tests conducted at home (57) ."}

{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T26","span":{"begin":177,"end":181},"obj":"Body_part"},{"id":"T27","span":{"begin":299,"end":303},"obj":"Body_part"}],"attributes":[{"id":"A26","pred":"uberon_id","subj":"T26","obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"A27","pred":"uberon_id","subj":"T27","obj":"http://purl.obolibrary.org/obo/UBERON_0002048"}],"text":"The TELICAST study by Johnston and colleagues showed that patients with asthma exacerbations that were given telithromycin, a ketolide, had an increase in symptom-free days and lung function tests conducted in the clinic compared with control subjects given placebo, but did not have an increase in lung function tests conducted at home (57) ."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T247","span":{"begin":72,"end":78},"obj":"Disease"},{"id":"T82446","span":{"begin":72,"end":78},"obj":"Disease"}],"attributes":[{"id":"A247","pred":"mondo_id","subj":"T247","obj":"http://purl.obolibrary.org/obo/MONDO_0004979"},{"id":"A89637","pred":"mondo_id","subj":"T82446","obj":"http://purl.obolibrary.org/obo/MONDO_0004979"}],"text":"The TELICAST study by Johnston and colleagues showed that patients with asthma exacerbations that were given telithromycin, a ketolide, had an increase in symptom-free days and lung function tests conducted in the clinic compared with control subjects given placebo, but did not have an increase in lung function tests conducted at home (57) ."}